General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0OIUPJ
ADC Name
AU2017363246B2 Conjugate79B
Synonyms
Conjugate79B
   Click to Show/Hide
Organization
MERSANA THERAPEUTICS, INC.
Drug Status
Investigative
Drug-to-Antibody Ratio
13.7
Structure
Antibody Name
XMT-1535
 Antibody Info 
Antigen Name
Sodium-dependent phosphate transport protein 2B (SLC34A2)
 Antigen Info 
Payload Name
AU2017363246B2+Conjugate79+Payload
 Payload Info 
Linker Name
AU2017363246B2+Conjugate79+Linker
 Linker Info 
Conjugate Type
Random conjugation through reduced inter-chain cysteines.
General Information of The ADMET Data Related to This ADC(2027 Update)
Absorption
Click To Hide/Show 1 Absorption Data Related to This Level
Standard Type Value Units Description Reference
Area Under the Concentration-Time Curve (AUC) 557 ug*hr/mL
ADC with an AUC0 to 336 of 3- 402to718 ug·hr/mL.
[1]
Distribution
Click To Hide/Show 1 Distribution Data Related to This Level
Standard Type Value Units Description Reference
Area Under the Concentration-Time Curve (AUC) 557 ug*hr/mL
ADC with an AUC0 to 336 of 3- 402to718 ug·hr/mL.
[1]
Metabolism
Click To Hide/Show 1 Metabolism Data Related to This Level
Standard Type Value Units Description Reference
Area Under the Concentration-Time Curve (AUC) 557 ug*hr/mL
ADC with an AUC0 to 336 of 3- 402to718 ug·hr/mL.
[1]
Excretion
Click To Hide/Show 2 Excretion Data Related to This Level
Standard Type Value Units Description Reference
Elimination Half-Life (t1/2) 160 hr
The terminal half-life is 160hr.
[1]
Area Under the Concentration-Time Curve (AUC) 557 ug*hr/mL
ADC with an AUC0 to 336 of 3- 402to718 ug·hr/mL.
[1]
References
Ref 1 Peptide-containing linkers for antibody-drug conjugates